NT-proBNP calculator Age year Women Height cm Weight kg Hemoglobin

Slides:

Advertisements

Similar presentations

It’s All Good We All Have a Purpose Raise the Roof How Low Can You Go?

Advertisements

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Fractions of Quantities

Use of Safety Monitoring Flow Sheets. Background  Flow sheets can serve as useful tools  Not required but recommended  Tailor for ease of use AND usefulness.

ICa i e sr lo. ONE Design Statement Nowadays, a lot people wants to be healthy or loss weight. In project 1, I decided to do a Calories calculator for.

4.3 Probability Distributions of Continuous Random Variables: For any continuous r. v. X, there exists a function f(x), called the density function of.

USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.

Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicity figure 2.1, combined.

Clinical Outcomes with Newer Antihyperglycemic Agents

Convert into scientific notation:

Aldosterone Targeted NeuroHormonal CombinEd with Natriuresis TherApy – Heart Failure Trial ATHENA-HF Trial Javed Butler, M.D., M.P.H, M.B.A. On behalf.

Biomarkers that “guide” therapy

Aldosterone Targeted NeuroHormonal CombinEd with Natriuresis TherApy – Heart Failure Trial ATHENA-HF Trial Javed Butler, Marvin A. Konstam, G. Michael.

2016 Annual Data Report, Vol 1, CKD, Ch 8

Clinical Outcomes with Newer Antihyperglycemic Agents

How to Calculate Your Body Mass Index (BMI)

The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent.

4.3 Probability Distributions of Continuous Random Variables:

Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations – A Systematic Review and Meta-analysis Julie Sze, MBBS, John.

Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study Am J Nephrol 2016;43:

Supplementary material

Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome Johanna E. Emmens, BSc, Jozine M. ter Maaten, MD, Yuya Matsue,

Stephen W. Waldo et al. JACC 2008;51:

Rapid access diagnostic pathway for suspected HF in primary care: The first 3 months... Dr Alan Japp Dr Sara Jenks Dr Clare McRae Dr Sebastian Peter.

children Growth charts

TO MEASURE AND RECORD THE HEIGHTS OF OUR FRIENDS

Grouped data Objective Task Identify the modal class. [Grade C]

Biomarkers in Heart Failure

Median NT-proBNP levels (pg/mL) by GFR and 60-day survival

Biomarker-Guided HF Therapy: Is It Cost-Effective?

The Heart Failure Team Heart Failure Care Map First 24 hours.

G. Michael Felker et al. JCHF 2014;2:

Area of a Composite Calculate the area of this shape Total Area =

Editorial Heart Failure Clinics

Chapter 9: Transition of Care in Chronic Kidney Disease

Overcoming Clinical Inertia

MK-0954 PN948 NOT APPROVED FOR USE (date)

Weighted Interval Scheduling

Embargoed until 10:45 a.m. CT/11:45 a.m. ET Sunday, Nov. 11, 2018

4.3 Probability Distributions of Continuous Random Variables:

ATHENA-HF Trial design: Patients with acute heart failure were randomized to spironolactone 100 mg daily (n = 182) vs. placebo/low-dose spironolactone.

Histograms © T Madas.

Refinement of survival prediction in patients undergoing lower extremity bypass surgery: Stratification by chronic kidney disease classification Christopher.

Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai Kidney International

Starter Questions Calculate the area of the following shapes :- a. 4m

A B D C Total adiponectin (μg/ml ) Hb ( g / dl ) r = p = 0.003

-.&- ·Af& Q 0 "i'/

Unit 3 Review (Calculator)

Histograms Example The table shows the weights of employees in a factory. Draw a histogram to represent these results. Weight (kg) Frequency 40 – 70 3.

Geriatrics American Journal of Kidney Diseases

Measurement Rounding.

Weighted Interval Scheduling

Quiz Page July 2012 American Journal of Kidney Diseases

Calculate x A B C D 10 cm 28 cm 10 cm2 100 cm2 QUESTION 1 Question 5

Measured maximal oxygen consumption (V′O2peak) in a) 58 men and b) 41 women, aged >70 years and free of chronic diseases. Measured maximal oxygen consumption.

Fig. 6. CXM correlates with age and growth velocity.

Calculate 9 x 81 = x 3 3 x 3 x 3 x 3 3 x 3 x 3 x 3 x 3 x 3 x =

Assessed for eligibility (n=71)

Receiver-operating characteristics analyses for predicting AKI progression or AKI progression with death. Receiver-operating characteristics analyses for.

Executive summary American Journal of Kidney Diseases

In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?

Risk factors Odds ratio 95% CI p Age >75 (referent: age 46-60) 2.17

Table 1. Characteristics (age, height, and weight) of the participants

Associations of peripartum biomarker levels with e' at 1 month postpartum (PP2). Associations of peripartum biomarker levels with e' at 1 month postpartum.

Changes in the plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) level from baseline to treatment titration and 3 months of therapy: full analysis.

Overall survival in all cases.

Standardised regression coefficients between blood variable levels and echocardiographic measurements. Standardised regression coefficients between blood.

Vivienne J. Halpern, MD, Roxana G. Kline, MD, Anthony J

Presentation transcript:

NT-proBNP calculator Age year Women Height cm Weight kg Hemoglobin Fig. S1 NT-proBNP calculator Age year Women Height cm Weight kg Hemoglobin g/dl Creatinine mg/dl BNP pg/ml AF Calculated NT-proBNP (80% interval) Yes No Yes No pg/ml ( ~ )

Fig. S2 Age<60 60<Age<70 70<Age<75 Age>75 r=0.920 log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP)

Fig. S3 eGFR<50 50<eGFR<70 70<eGFR<90 eGFR>90 log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP)

(+) HF hospitalization (+) CVD hospitalization (-) CVD hospitalization Fig. S4 (+) HF hospitalization (+) CVD hospitalization (-) CVD hospitalization r=0.930 r=0.918 r=0.918 log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Calculated NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP) log10 (Measured NT-proBNP)